Incidence luteolin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Cerebrum Cell Line, Tumor Plant Components, Aerial Chorioallantoic Membrane Plant Leaves Pineal Gland HT29 Cells Cells, Cultured Flowers Microglia Microvessels Fundus Oculi Feces Colon 3T3-L1 Cells Liver Jejunum

Organisms20

Lonicera Perilla frutescens Chrysanthemum Chamomile Lamiaceae Melissa Achillea Ligustrum Impatiens Plants, Medicinal Mice, Inbred ICR Rats, Sprague-Dawley Sinorhizobium meliloti Mice, Inbred BALB C Rhizobium Leishmania donovani Mice, Inbred C57BL Fabaceae Rats, Inbred F344 Mice, Nude

Diseases28

Neoplasms Postoperative Complications Prostatic Neoplasms Skin Neoplasms Encephalitis Kidney Tubular Necrosis, Acute Recurrence Lung Neoplasms Breast Neoplasms Retinal Neovascularization Acute Disease Neoplasms, Radiation-Induced Brain Damage, Chronic HIV Infections Occupational Diseases Disease Models, Animal Inflammation Neoplasm Invasiveness Stroke Myocardial Infarction Colonic Neoplasms Adenocarcinoma Myocardial Reperfusion Injury Disease Progression Cerebrovascular Disorders Stomach Neoplasms Neoplasms, Second Primary Intraoperative Complications

Chemicals and Drugs71

Flavonoids Apigenin Quercetin Kaempferols Expectorants Flavonols Glucosides Flavones Plant Extracts Flavanones Propylene Glycol Carboxymethylcellulose Sodium Sodium Oxybate Pharmaceutical Solutions Picrates Anticarcinogenic Agents Anti-Allergic Agents Anti-Inflammatory Agents Luteolin Phenols Antioxidants Drugs, Chinese Herbal Free Radical Scavengers Proto-Oncogene Proteins c-akt Cyclohexanones Oils, Volatile Monocarboxylic Acid Transporters Fluorenes Glycosides Catechols alpha-Glucosidases Biflavonoids Antineoplastic Agents DNA, Kinetoplast Biphenyl Compounds Oncogene Protein v-akt Amsacrine Polyphenols Lipopolysaccharides Receptor, IGF Type 1 NF-kappa B L-Lactate Dehydrogenase Triterpenes Glucuronides Enzyme Inhibitors Transcription Factor AP-1 Tumor Necrosis Factor-alpha Extracellular Signal-Regulated MAP Kinases Cyclooxygenase 2 Transcription Factors, General Carcinogens Cytokines Topoisomerase II Inhibitors RNA, Messenger Neuroprotective Agents Catechol O-Methyltransferase Antiparkinson Agents Mitogen-Activated Protein Kinases Ubiquitin JNK Mitogen-Activated Protein Kinases Proteasome Endopeptidase Complex Interleukin-6 p38 Mitogen-Activated Protein Kinases Inflammation Mediators Antineoplastic Agents, Phytogenic Topoisomerase I Inhibitors I-kappa B Kinase Ribosomal Protein S6 Kinases, 70-kDa Immunosuppressive Agents Reactive Oxygen Species Culture Media, Conditioned

Analytical, Diagnostic and Therapeutic Techniques and Equipment52

Incidence Risk Factors Administration, Ophthalmic Retrospective Studies Prospective Studies Cohort Studies Follow-Up Studies Registries Treatment Outcome Prevalence Population Surveillance Risk Assessment Poisson Distribution Risk Survival Rate Chromatography, High Pressure Liquid Phytotherapy Proportional Hazards Models Prognosis SEER Program Survival Analysis Double-Blind Method Multivariate Analysis Blotting, Western Epidemiologic Methods Administration, Oral Confidence Intervals Xenograft Model Antitumor Assays Case-Control Studies Longitudinal Studies Regression Analysis Hospitalization Logistic Models Reverse Transcriptase Polymerase Chain Reaction Odds Ratio Disease Models, Animal Severity of Illness Index Mass Screening Chi-Square Distribution Carcinogenicity Tests Random Allocation Kaplan-Meier Estimate Heart Function Tests Questionnaires Models, Statistical Morbidity Epidemiologic Studies Predictive Value of Tests Enzyme-Linked Immunosorbent Assay Drug Therapy, Combination Culture Media, Conditioned Drug Evaluation, Preclinical

Psychiatry and Psychology1

Phenomena and Processes32

Solar Energy Metabolic Detoxication, Phase I Time Factors Apoptosis Dose-Response Relationship, Drug Poisson Distribution Signal Transduction Cell Proliferation Molecular Structure Seasons Pregnancy Risk Cell Survival Diet Phosphorylation M Phase Cell Cycle Checkpoints Down-Regulation Intestinal Absorption Cell Cycle Checkpoints Odds Ratio Chi-Square Distribution Biotransformation Symbiosis DNA Fragmentation Gene Expression Regulation Drug Synergism Cell Movement Structure-Activity Relationship Methylation Ultraviolet Rays Cell Growth Processes Gene Expression Regulation, Neoplastic

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena2

Age Distribution Sex Distribution

Technology, Industry, Agriculture1

Information Science8

Incidence Registries Prevalence Survival Rate SEER Program Databases, Factual Questionnaires Morbidity

Named Groups4

Infant, Newborn European Continental Ancestry Group African Continental Ancestry Group Ethnic Groups

Health Care48

Incidence Risk Factors Retrospective Studies Prospective Studies Solar Energy Cohort Studies Age Distribution Follow-Up Studies Registries Treatment Outcome Sex Distribution Prevalence Population Surveillance Risk Assessment Poisson Distribution Seasons Risk Survival Rate Proportional Hazards Models SEER Program Survival Analysis Double-Blind Method Multivariate Analysis Epidemiologic Methods Confidence Intervals Case-Control Studies Longitudinal Studies Regression Analysis Hospitalization Logistic Models Odds Ratio Severity of Illness Index Mass Screening Chi-Square Distribution Random Allocation Comorbidity Disease Outbreaks Kaplan-Meier Estimate Urban Population Rural Population Ethnic Groups Questionnaires Models, Statistical Morbidity Epidemiologic Studies Occupational Exposure Predictive Value of Tests Ultraviolet Rays

Geographicals23

United States Japan Sweden Minnesota England Denmark France Netherlands Great Britain India China Italy Finland Europe Brazil Spain Taiwan Israel Norway California Wales Germany Scotland

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Incidence Flavonoids Apigenin Quercetin Lonicera Perilla frutescens Chrysanthemum Chamomile Kaempferols Lamiaceae Expectorants Flavonols Risk Factors Glucosides Flavones Melissa Administration, Ophthalmic Plant Extracts Retrospective Studies Flavanones Prospective Studies Propylene Glycol Carboxymethylcellulose Sodium Sodium Oxybate Solar Energy Pharmaceutical Solutions Achillea Cohort Studies Ligustrum Metabolic Detoxication, Phase I Time Factors Picrates Age Distribution Follow-Up Studies Registries Cerebrum Infant, Newborn Neoplasms Impatiens Treatment Outcome Cell Line, Tumor Sex Distribution Anticarcinogenic Agents Anti-Allergic Agents Apoptosis Anti-Inflammatory Agents Luteolin Plants, Medicinal Prevalence United States Plant Components, Aerial Population Surveillance Postoperative Complications Dose-Response Relationship, Drug Phenols Mice, Inbred ICR Antioxidants Risk Assessment Japan Poisson Distribution Drugs, Chinese Herbal Free Radical Scavengers Proto-Oncogene Proteins c-akt Signal Transduction Cyclohexanones Oils, Volatile Cell Proliferation Monocarboxylic Acid Transporters Molecular Structure Prostatic Neoplasms Skin Neoplasms Rats, Sprague-Dawley Sinorhizobium meliloti Seasons Chorioallantoic Membrane Pregnancy Risk Plant Leaves Mice, Inbred BALB C Survival Rate Fluorenes Sweden Pineal Gland HT29 Cells Glycosides Encephalitis Cell Survival Catechols alpha-Glucosidases Biflavonoids Antineoplastic Agents Cells, Cultured Kidney Tubular Necrosis, Acute Diet Flowers Phosphorylation Chromatography, High Pressure Liquid Phytotherapy Proportional Hazards Models Prognosis

No FAQ available that match "incidence luteolin"